Global market research — built on pharma, the most regulated industry we serve, and expanded to be trusted across industries

MENA and the United States — how we grew

As pharmaceutical clients looked beyond Europe, two geographies pulled on us with equal force. The Middle East and North Africa — fast-growing, under-researched, hungry for launch and access intelligence that respected SFDA, DHA, MOHAP, and local clinical reality. And the United States — the world's largest pharmaceutical market, where our clients needed the same rigour we had built in London, executed at American scale.

We answered by growing where the work was, not where it was easy. A regional office in Greater Cairo, followed by field offices in Al Khobar, Dubai and Kuwait City, gave us Arabic–English field teams, physician access across the GCC and North Africa, and on-the-ground execution that desk research could never replicate. US headquarters in Sheridan, Wyoming followed — not as a relocation, but as the natural home for a firm whose clients and ambition had become genuinely global. London remained our European regional leadership office and the place where BioNixus began. BioNixus is fully operational in LATAM, delivered from its USA offices with BioNixus field teams in Brazil and LATAM, and is in the process of opening a São Paulo office by the end of 2026.